The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden
24 affiliations
- 1Murdoch Children's Research Institute Parkville Victoria Australia
- 2National Allergy Centre of Excellence Parkville Victoria Australia
- 3Centre for Food Allergy Research Parkville Victoria Australia
- 4The University of Queensland Brisbane Queensland Australia
- 5The Children's Hospital at Westmead Westmead New South Wales Australia
- 6The University of Sydney Camperdown New South Wales Australia
- 7Queensland University of Technology Brisbane Queensland Australia
- 8The University of New South Wales Randwick New South Wales Australia
- 9Alfred Health Prahran Victoria Australia
- 10Austin Health Heidelberg Victoria Australia
- 11Monash University Clayton Victoria Australia
- 12Sir Charles Gairdner Hospital Nedlands Western Australia Australia
- 13Perth Children's Hospital Nedlands Western Australia Australia
- 14The University of Western Australia Crawley Western Australia Australia
- 15National Allergy Council Sydney New South Wales Australia
- 16Western Sydney University Campbelltown New South Wales Australia
- 17Campbelltown Hospital Campbelltown New South Wales Australia
- 18Australasian Society of Allergy and Clinical Immunology Australia
- 19The Kids Research Institute Australia Nedlands Western Australia Australia
- 20The University of Melbourne Parkville Victoria Australia
- 21Macquarie University Sydney New South Wales Australia
- 22The Royal Hobart Hospital Hobart Tasmania Australia
- 23The University of Tasmania Hobart Tasmania Australia
- 24The Royal Children's Hospital Melbourne Parkville Victoria Australia
Abstract
Australia has one of the highest rates of food allergy, anaphylaxis hospital admissions and anaphylaxis fatalities worldwide. These trends and sustained advocacy prompted a 2019 Parliamentary Inquiry into Allergies and Anaphylaxis. Among 250 submissions, the Centre for Food Allergy Research called for a national research‐coordinating centre and comprehensive allergy research funding. In response to the inquiry, the Australian Government funded the National Allergy Centre of Excellence (NACE) in 2022, and its partner organisation, the National Allergy Council (NAC), to improve health, save lives and reduce the national burden of allergic disease. Here we describe the establishment and early impacts of the NACE. The NACE was established to build critical national research infrastructure and collaboration to transform consumer‐centred allergy care. Four interconnected Pillars underpin the plan of action: (1) Transforming Allergy Care, codesigning national trials and embedded clinical research to address knowledge and practice gaps; (2) BioRepository and Discovery, developing Australia's first national Allergy BioRepository (ALBI) to support data‐driven discovery; (3) Evidence and Translation, providing living evidence surveillance and synthesis to accelerate translation into policy and practice; and (4) Training and Innovation, building workforce capacity through postgraduate scholarships and fellowships. In just 3 years, the NACE has become a global exemplar, secured further funding and demonstrated excellence in high‐impact research, rapid translation into policy and practice, and improved outcomes for people living with allergic disease. The NACE has united over 500 drug, food, insect and respiratory allergy experts. Over 1500 individuals with allergies are enrolled in five research programs initiated in clinical care, including more than 500 families in a national, standardised peanut oral immunotherapy program (ADAPT) and NACE‐led evaluation study. The ALBI design and build are well‐advanced, and over 5000 academic articles have been assessed through Australia's first drug and food allergy living evidence collections, underpinning clinical guidelines, public health programs and resources. The NACE has been recognised as an European Academy of Allergy and Clinical Immunology Advanced Research Centre and a World Allergy Organisation Center of Excellence. In December 2025, the NACE‐NAC partnership secured further Federal Government funding to continue driving national impact.
Related
- Validation of EUCAST 2026 breakpoints for Brucella species using routine laboratory methods: A comprehensive French National Reference Centre study
- Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
- IgE ‐Binding Components in Fungi and Parasites: From Infection Severity to Allergy and Allergy Protection: An EAACI Position Paper
- Editorial: Advances in molecular diagnostics of allergy: novel allergens, biomarkers, and technical developments
- From Non–IgE Mediated Cow’s Milk Allergy to Rickets: Consequences of Unwarranted Dairy Exclusion
BibTeX
@article{young2026national,
title = {{The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden}},
author = {A. Young and J. J. Koplin and D. E. Campbell and J. M. Davies and H. Edmund and T. Jamieson and C. J. Hornung and T. O'Farrell and D. West and E. Kayes and L. A. Gray and R. L. Peters and L. Gamble and K. Gwynne and J. Lee and M. Lucas and C. H. Katelaris and M. D. O'Sullivan and D. J. Palmer and J. Trubiano and S. van Nunen and S. L. Vale and T. Wanandy and K. P. Perrett},
journal = {Clinical and Experimental Allergy},
year = {2026},
month = jul,
doi = {10.1111/cea.70392},
url = {https://doi.org/10.1111/cea.70392},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden
AU - A. Young
AU - J. J. Koplin
AU - D. E. Campbell
AU - J. M. Davies
AU - H. Edmund
AU - T. Jamieson
AU - C. J. Hornung
AU - T. O'Farrell
AU - D. West
AU - E. Kayes
AU - L. A. Gray
AU - R. L. Peters
AU - L. Gamble
AU - K. Gwynne
AU - J. Lee
AU - M. Lucas
AU - C. H. Katelaris
AU - M. D. O'Sullivan
AU - D. J. Palmer
AU - J. Trubiano
AU - S. van Nunen
AU - S. L. Vale
AU - T. Wanandy
AU - K. P. Perrett
PY - 2026
DA - 2026/07/31
JO - Clinical and Experimental Allergy
DO - 10.1111/cea.70392
UR - https://doi.org/10.1111/cea.70392
AB - Australia has one of the highest rates of food allergy, anaphylaxis hospital admissions and anaphylaxis fatalities worldwide. These trends and sustained advocacy prompted a 2019 Parliamentary Inquiry into Allergies and Anaphylaxis. Among 250 submissions, the Centre for Food Allergy Research called for a national research‐coordinating centre and comprehensive allergy research funding. In response to the inquiry, the Australian Government funded the National Allergy Centre of Excellence (NACE) in 2022, and its partner organisation, the National Allergy Council (NAC), to improve health, save lives and reduce the national burden of allergic disease. Here we describe the establishment and early impacts of the NACE. The NACE was established to build critical national research infrastructure and collaboration to transform consumer‐centred allergy care. Four interconnected Pillars underpin the plan of action: (1) Transforming Allergy Care, codesigning national trials and embedded clinical research to address knowledge and practice gaps; (2) BioRepository and Discovery, developing Australia's first national Allergy BioRepository (ALBI) to support data‐driven discovery; (3) Evidence and Translation, providing living evidence surveillance and synthesis to accelerate translation into policy and practice; and (4) Training and Innovation, building workforce capacity through postgraduate scholarships and fellowships. In just 3 years, the NACE has become a global exemplar, secured further funding and demonstrated excellence in high‐impact research, rapid translation into policy and practice, and improved outcomes for people living with allergic disease. The NACE has united over 500 drug, food, insect and respiratory allergy experts. Over 1500 individuals with allergies are enrolled in five research programs initiated in clinical care, including more than 500 families in a national, standardised peanut oral immunotherapy program (ADAPT) and NACE‐led evaluation study. The ALBI design and build are well‐advanced, and over 5000 academic articles have been assessed through Australia's first drug and food allergy living evidence collections, underpinning clinical guidelines, public health programs and resources. The NACE has been recognised as an European Academy of Allergy and Clinical Immunology Advanced Research Centre and a World Allergy Organisation Center of Excellence. In December 2025, the NACE‐NAC partnership secured further Federal Government funding to continue driving national impact.
SN - 0954-7894
SN - 1365-2222
ER -